Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1109 clinical trials
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

with immune checkpoint inhibitors in HLA-A*02+ patients with recurrent, locally advanced or metastatic human papillomavirus strain 16 positive (HPV16+) solid tumors. The study includes patients with

  • 4 views
  • 08 Aug, 2022
  • 6 locations
  • 0 views
  • 08 Aug, 2022
  • 1 location
A Study of GFH925 in Patients With Advanced Solid Tumors With KRAS G12C Mutations

Phase I: To evaluate the safety and tolerability of GFH925 in subjects with KRAS G12C mutant advanced solid tumors and estimate the maximum tolerated dose (MTD) and/or a recommended phase 2 dose

  • 0 views
  • 09 Aug, 2022
  • 1 location
A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors

(RP2D) of YH001 in subjects with advanced solid tumors.

  • 0 views
  • 11 Aug, 2022
  • 1 location
A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors

This is a Phase 1 study to assess the safety and clinical activity of KSQ-4279 alone and in combination in patients with advanced solid tumors.

  • 0 views
  • 22 Apr, 2022
  • 2 locations
Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors (EVICTION-2)

advanced-stage solid tumors. Part 1 will be a dose escalation of IV ICT01 administered on the first day of every 21-day cycle (CnD1) to patients with advanced-stage solid tumors in combination with

  • 0 views
  • 14 May, 2022
  • 1 location
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor

This is an open-label phase 1 study with an escalation part and an expansion part.

  • 0 views
  • 11 Jul, 2022
  • 1 location
Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.

Dose escalation of ORIN1001 in patients with advanced solid tumors. Dose escalation of ORIN1001 in combination with standard of care in patients with esophageal carcinoma, metastatic

  • 0 views
  • 29 May, 2022
  • 1 location
  • 0 views
  • 03 Jun, 2022
A Clinical Study to Evaluate the Safety and Tolerability of JS012 in Advanced or Metastatic Solid Tumors

The purpose of this phase I clinical study was to evaluate the safety and tolerability of JS012 monotherapy and combination with chemotherapy in patients with Advanced or Metastatic Solid Tumors

  • 0 views
  • 03 Jun, 2022
  • 1 location